Edward M. Kaye M.D.

CIK: 0001522780

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)31 (44.9%)

Position reduction

Option Exercises (M)17 (24.6%)

Derivative conversions

Awards (A)18 (26.1%)

Compensation grants

Other (G, F, J, C, D, …)3 (4.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

CYTK

CYTOKINETICS INC

Director

STOK

Stoke Therapeutics, Inc.

Director

RNAM

Avidity Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (69 total)

CYTK
CYTOKINETICS INC
Oct 16, 2026
Award(A)
Direct
195 shares at avg. $63.92$12K
STOK
Stoke Therapeutics, Inc.
Aug 18, 2026
Sale(S)
Direct
637 shares at avg. $32.47$21K
STOK
Stoke Therapeutics, Inc.
Aug 18, 2026
Sale(S)
Direct
11.9K shares at avg. $32.01$382K
STOK
Stoke Therapeutics, Inc.
Aug 14, 2026
Exercise(M)
Direct
26.3K shares-
CYTK
CYTOKINETICS INC
Jul 15, 2026
Award(A)
Direct
151 shares at avg. $82.62$12K
STOK
Stoke Therapeutics, Inc.
Jun 3, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
17.8K shares-
CYTK
CYTOKINETICS INC
Jun 1, 2026
Sale(S)
Direct
2.9K shares at avg. $76.09$223K
CYTK
CYTOKINETICS INC
May 27, 2026
Award(A)
Direct
2.9K shares-
CYTK
CYTOKINETICS INC
Apr 15, 2026
Award(A)
Direct
191 shares at avg. $65.37$12K
STOK
Stoke Therapeutics, Inc.
Mar 15, 2026
Exercise(M)
Direct
26.3K shares-
STOK
Stoke Therapeutics, Inc.
Mar 15, 2026
Exercise(M)
Direct
35.5K shares-
RNAM
Avidity Biosciences, Inc.
Feb 27, 2026
Disposition(D)
Direct
6.7K shares-
CYTK
CYTOKINETICS INC
Jan 15, 2026
Award(A)
Direct
197 shares at avg. $63.44$12K
STOK
Stoke Therapeutics, Inc.
Dec 8, 2025
Sale(S)
Direct
1.3K shares at avg. $33.10$44K
STOK
Stoke Therapeutics, Inc.
Dec 8, 2025
Sale(S)
Direct
8.3K shares at avg. $32.52$269K
STOK
Stoke Therapeutics, Inc.
Dec 8, 2025
Sale(S)
Direct
3.8K shares at avg. $31.44$120K
STOK
Stoke Therapeutics, Inc.
Dec 5, 2025
Sale(S)
Direct
500 shares at avg. $31.85$16K
STOK
Stoke Therapeutics, Inc.
Dec 5, 2025
Sale(S)
Direct
1.7K shares at avg. $31.15$52K
STOK
Stoke Therapeutics, Inc.
Dec 5, 2025
Sale(S)
Direct
6.4K shares at avg. $31.33$199K
STOK
Stoke Therapeutics, Inc.
Dec 4, 2025
Sale(S)
Direct
1.2K shares at avg. $31.32$39K
STOK
Stoke Therapeutics, Inc.
Dec 4, 2025
Sale(S)
Direct
5.2K shares at avg. $30.76$161K
STOK
Stoke Therapeutics, Inc.
Dec 3, 2025
Exercise(M)
Direct
26.3K shares-
STOK
Stoke Therapeutics, Inc.
Dec 3, 2025
Sale(S)
Direct
419 shares at avg. $30.34$13K
STOK
Stoke Therapeutics, Inc.
Dec 3, 2025
Sale(S)
Direct
651 shares at avg. $30.85$20K
STOK
Stoke Therapeutics, Inc.
Dec 2, 2025
Sale(S)
Direct
661 shares at avg. $29.56$20K

		Type	Shares	Price		Ownership
Oct 16, 2026	CYTK CYTOKINETICS INC	Award(A)	195	$63.92	$12,464	Direct
Aug 18, 2026	STOK Stoke Therapeutics, Inc.	Sale(S)	637	$32.47	$20,682	Direct
Aug 18, 2026	STOK Stoke Therapeutics, Inc.	Sale(S)	11,930	$32.01	$381,846	Direct
Aug 14, 2026	STOK Stoke Therapeutics, Inc.	Exercise(M)	26,250	-	$0	Direct
Jul 15, 2026	CYTK CYTOKINETICS INC	Award(A)	151	$82.62	$12,476	Direct
Jun 3, 2026	STOK Stoke Therapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	17,786	-	-	Direct
Jun 1, 2026	CYTK CYTOKINETICS INC	Sale(S)	2,933	$76.09	$223,172	Direct
May 27, 2026	CYTK CYTOKINETICS INC	Award(A)	2,851	-	$0	Direct
Apr 15, 2026	CYTK CYTOKINETICS INC	Award(A)	191	$65.37	$12,486	Direct
Mar 15, 2026	STOK Stoke Therapeutics, Inc.	Exercise(M)	26,250	-	$0	Direct
Mar 15, 2026	STOK Stoke Therapeutics, Inc.	Exercise(M)	35,500	-	$0	Direct
Feb 27, 2026	RNAM Avidity Biosciences, Inc.	Disposition(D)	6,692	-	$0	Direct
Jan 15, 2026	CYTK CYTOKINETICS INC	Award(A)	197	$63.44	$12,498	Direct
Dec 8, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	1,331	$33.10	$44,062	Direct
Dec 8, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	8,274	$32.52	$269,070	Direct
Dec 8, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	3,825	$31.44	$120,253	Direct
Dec 5, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	500	$31.85	$15,923	Direct
Dec 5, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	1,681	$31.15	$52,358	Direct
Dec 5, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	6,367	$31.33	$199,481	Direct
Dec 4, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	1,231	$31.32	$38,550	Direct
Dec 4, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	5,222	$30.76	$160,647	Direct
Dec 3, 2025	STOK Stoke Therapeutics, Inc.	Exercise(M)	26,250	-	-	Direct
Dec 3, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	419	$30.34	$12,712	Direct
Dec 3, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	651	$30.85	$20,082	Direct
Dec 2, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	661	$29.56	$19,540	Direct

1-25 of 69 transactions

About Kaye Edward M. MD

Kaye Edward M. MD (SEC CIK 0001522780) files insider reports with the SEC as Director of CYTOKINETICS INC (CYTK), Director of Stoke Therapeutics, Inc. (STOK) and Director of Avidity Biosciences, Inc. (RNAM).

Signal8 holds 40 ownership filings by Kaye Edward M. MD, all Form 4s, filed between Oct 3, 2024 and Oct 20, 2026. Those filings report 69 transactions, from Oct 1, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kaye Edward M. MD's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Kaye Edward M. MD

Oct 16, 2026: Grant or award of CYTK shares (Form 4, code A).
Aug 18, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
Aug 14, 2026: Option exercise of STOK shares (Form 4, code M).
Jul 15, 2026: Grant or award of CYTK shares (Form 4, code A).
Jun 3, 2026: Grant or award of STOK derivative securities (Form 4, code A).

Other insiders filing for CYTOKINETICS INC (CYTK)

Blum Robert I, President & CEO
Wysenski Nancy, Director
Harrington Robert Arthur, Director
Daly James M, Director
WIERENGA WENDELL, Director
HENDERSON JOHN T, Director

How to read Form 4 transaction codes